BlackRock Fund Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History

BlackRock Fund Advisors’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$120K	Buy	56,990 +3,140	+6%	+$7.33K	﹤0.01%	3560
2016 Q3	$142K	Buy	53,850 +7,614	+16%	+$19K	﹤0.01%	3553
2016 Q2	$88K	Buy	46,236 +12,946	+39%	+$34K	﹤0.01%	3706
2016 Q1	$98K	Sell	33,290 -2,343	-7%	-$6.68K	﹤0.01%	3670
2015 Q4	$111K	Buy	35,633 +1,056	+3%	+$3.61K	﹤0.01%	3711
2015 Q3	$109K	Sell	34,577 -912	-3%	-$3.51K	﹤0.01%	3679
2015 Q2	$135K	Buy	35,489 +4,264	+14%	+$16.4K	﹤0.01%	3664
2015 Q1	$147K	Buy	31,225 +4,337	+16%	+$25K	﹤0.01%	3556
2014 Q4	$171K	Buy	26,888 +1,926	+8%	+$11.3K	﹤0.01%	3527
2014 Q3	$122K	Sell	24,962 -1,819	-7%	-$10.5K	﹤0.01%	3606
2014 Q2	$205K	Buy	+26,781	New	+$213K	﹤0.01%	3483

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BlackRock Fund Advisors's OCRX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ocera Therapeutics, Inc. (OCRX) stake by 5.8% in Q4 2016, buying an estimated $7.33K and bringing the position to 56,990 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #3560.

BlackRock Fund Advisors first reported a position in OCRX in Q2 2014 and has held it in 11 quarters since. The position peaked at $205K in Q2 2014. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

BlackRock Fund Advisors held 56,990 shares of Ocera Therapeutics, Inc. worth $120K as of Q4 2016.
BlackRock Fund Advisors bought 3,140 Ocera Therapeutics, Inc. shares in Q4 2016, an estimated $7.33K.
Ocera Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3560 holding.
BlackRock Fund Advisors first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Ocera Therapeutics, Inc. position peaked at $205K in Q2 2014.
36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.